Hero Image

Overview

Andrew Radsch is an experienced trial lawyer whose practice focuses on complex patent, trade secret and other technology-focused disputes in federal courts, before the Patent Trial and Appeal Board and at the International Trade Commission.

Representing both plaintiffs and defendants in courts across the country, Andrew has litigated cases across a broad spectrum of industries and technologies, including network security, wireless communications, cloud computing, streaming media, semiconductors, consumer electronics, medical devices and consumer care products. He regularly advises clients on offensive and defensive intellectual property strategies, and represents clients in contested Section 1782 proceedings for obtaining discovery in aid of foreign proceedings. He has also served as counsel of record in more than 35 post-grant proceedings at the PTAB.

In addition to his first chair trial experience, Andrew has devised winning strategies and arguments that resulted in early favorable resolution for his clients, including multiple no-fee, walkaway settlements in both non-practicing entity and competitor suits.

Prior to joining Munger Tolles, Andrew was a partner at a multinational law firm. During law school, Andrew was an extern for the Honorable Deborah A. Batts at the U.S. District Court for the Southern District of New York.

In his pro bono practice, Andrew frequently represents victims of domestic violence in obtaining restraining orders, child custody and financial support, as well as refugees seeking asylum.

Background Pattern
Background Pattern

Experience

Andrew’s selected work experience prior to joining Munger, Tolles & Olson includes representation of:

Technology, Media, and Telecommunications

Yangtze Memory Technologies Company, Ltd. as lead counsel for the patent owner in a 22-patent infringement suit concerning 3D NAND semiconductor technology. This complex suit has spanned the district court, PTAB and Federal Circuit, as well as mandamus proceedings before the Supreme Court.

An internet technology company as lead counsel in an eleven-patent suit relating to its video sharing app.

A major multinational consumer electronics company as co-lead counsel in a six-patent suit concerning user authentication, biometric and electronic payment technologies. After securing key inventor and expert admissions, plaintiff dropped one patent and the court granted summary judgment of § 101 subject matter ineligibility for the five remaining patents.

Palo Alto Networks in a 13-patent infringement suit relating to network security, as petitioner in more than 15 related PTAB proceedings, and in appeals from IPR proceedings. Led invalidity and IPR strategy, as well as the resulting appeals, in which he achieved a clean sweep for the client.

Roku and several TCL Electronics Holdings Ltd. entities in a multi-patent infringement lawsuit concerning video streaming and smart TV functionality and interfaces. Achieved a very favorable settlement that included a license for all of Roku’s TV partners.

A major Japanese electronics manufacturer in a multi-patent infringement litigation involving semiconductors and various features of digital cameras. Obtained a highly favorable settlement shortly after the court issued its Markman order.

Life Sciences & Medical Devices

Upsher-Smith in a breach of contract action arising from a patent litigation settlement agreement. Won dismissal with prejudice of all counterclaims and, on the eve of trial, secured a very favorable settlement.

AstraZeneca LP in a 19-day bench trial involving pediatric asthma drug Pulmicort Respules® and patents concerning methods of treatment and sterilized compositions.

Nova Biomedical Corp. in a suit alleging misappropriation of trade secrets, breach of contract and unfair competition relating to blood glucose meters. After a three-week trial, a federal jury unanimously found for Nova on all counts.

A pharmaceutical company in obtaining substantial discovery, and defeating numerous motions to quash or limit discovery, in connection with discovery in aid of a German litigation under 28 U.S.C. § Section 1782 concerning recombinant Factor VIII for hemophiliacs.

Abiomed in a declaratory judgment action seeking a declaration of non-infringement relating to Abiomed’s flagship Impella® heart pumps.

Education
Columbia Law School (J.D., 2006)
University of California, Santa Barbara (B.A., 2002) Highest Honors
Admissions
California
New York
U.S. Court of Appeals, Federal Circuit
U.S. District Court, Central District of California
U.S. District Court, Northern District of California
U.S. District Court, Eastern District of Texas
U.S. District Court, Western District of Texas
U.S. District Court, Eastern District of New York
U.S. District Court, Southern District of New York

More

  • Legal 500, 2024
  • Daily Journal, Top Intellectual Property Lawyers in California, 2024, 2025
  • Federal Circuit Bar Association, George Hutchinson Committee Award, 2019
  • Volunteer, YMCA Project Cornerstone, 2024-2025
  • Volunteer and Mentor, Peninsula Bridge, 2023-2025
  • Vice-Chair, Mock Argument Committee, Federal Circuit Bar Association, 2019-2024

Publications

Speaking Engagements

  • Speaker, “IP Licensing Pitfalls in Deals and Litigation,” World IP Review Patents Live Webinar, April 13, 2021
  • Speaker, “Two Years Later: TC Heartland’s Impact on Patent Litigation Explored,” The Knowledge Group, December 13, 2019
  • Speaker, “Litigation Trends: US & International – The Impact on Your IP Strategy,” Centerforce IP Strategy Summit, December 3, 2019
  • Speaker, “Excellence in Appellate Advocacy, The Mock Argument Series,” Federal Circuit Bar Association Conference, March 21, 2019
  • Speaker, “IP Portfolio Management and Licensing Strategies – In-house Counsel Day-to-Day Challenges in Securing and Protecting Patents,” World IP Review Technology Patent Network Conference, February 21, 2019